In December 2022, the World Health Organization endorsed a single-dose schedule for HPV vaccination for the primary target age group (9-14 years-old). Since then, additional data continue to build the evidence base in support of its use. As global leaders gather at the World Health Assembly to assess progress and chart priorities, IVAC has joined […]
Read More >
By Dr. Anita Shet and Dr. Dickson Awah Originally posted on reliefweb.int On a busy street in N’Djamena, Chad, a town crier announces the start of a measles vaccine campaign. A year ago, the same town crier was rallying for COVID-19 vaccine campaigns. Conflict was no stranger to the people of Chad, but his call […]
Read More >
World Immunization Week is the last week in April and this year’s theme is The Big Catch Up. Vaccine expert Dr. William Moss returns to the podcast to talk with Dr. Josh Sharfstein about how major setbacks in global vaccine coverage over the past few years are seeding the deadly threat of a measles resurgence. They discuss contributing factors […]
Read More >
When: April 26th, 2023 Recording: https://youtu.be/DFRzAPvfEO8 Slides: (download PDF) Description: As part of World Immunization Week (2023), IVAC is hosted a webinar to highlight exciting new vaccines and immunization technologies that are on the horizon. An international panel of distinguished experts presented on cutting-edge developments in vaccines. The experts covered new vaccines that have the […]
Read More >
Gender roles and norms can profoundly impact immunization uptake and health outcomes for women, children, families, and communities. In order to support immunization coverage and reach zero-dose children, it is essential to understand and address how gender can influence the access and delivery of vaccines. In recognition of International Women’s Day on March 8, IVAC […]
Read More >
Originally posted March 9, 2023 on StopPneumonia.org Pneumonia is the leading infectious killer of children under five, claiming the lives of an estimated 672,000 children in 2019 alone. This number is greater than all child deaths from HIV/AIDS, malaria, and tuberculosis combined. The life-saving potential of the pneumococcal conjugate vaccine (PCV) is well known. PCV […]
Read More >
World Tuberculosis Day is observed annually on March 24 to raise awareness about this devastating disease, which infects more than 10 million people and kills approximately 1.6 million each year—equal to one TB death every 20 seconds. TB is currently one of the world’s leading infectious killers, second only to COVID-19, though it has received […]
Read More >
COVID-19 vaccine uptake has plateaued globally, largely in part due to rampant misinformation about the vaccine’s safety and effectiveness. To combat this phenomenon, IVAC launched VIRA, the COVID-19 vaccine chatbot, at the peak of the pandemic in July 2021. VIRA was developed in partnership with IBM Research with the goal of providing evidence-based, credible, and […]
Read More >
IVAC health economists, led by Bryan Patenaude, ScD, have recently published several papers focusing on the cost of procuring and delivering life-saving vaccines to increase coverage and meet Immunization Agenda 2030 (IA 2030) targets. Despite the sizable global investment in immunization programs over the past few decades, a considerable gap remains between the funding available […]
Read More >
Pneumonia continues to be the number one infectious killer of young children globally. In the World Health Organization (WHO)’s Eastern Mediterranean (EMRO) region, each year an estimated 923,000 children under 5 years of age (U5) die, with pneumonia accounting for over 20% of deaths among this age group (UNICEF, 2022). PCV protects against infections caused […]
Read More >